Julie K Heimbach

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. ncbi request reprint Living donor liver transplantation using a right lobe graft in an adult with situs inversus
    Julie K Heimbach
    Division of Transplantation Surgery, Mayo Clinic, 200 First Street, Rochester, MN 55905, USA
    Liver Transpl 11:111-3. 2005
  2. doi request reprint Infrastructure, logistics and regulation of transplantation: UNOS
    Julie K Heimbach
    Division of Transplantation Surgery, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA Electronic address
    Anesthesiol Clin 31:659-66. 2013
  3. ncbi request reprint Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma
    Julie K Heimbach
    William J von Liebig Transplant Center, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Transplantation 82:1703-7. 2006
  4. pmc Trans-peritoneal fine needle aspiration biopsy of hilar cholangiocarcinoma is associated with disease dissemination
    Julie K Heimbach
    William J von Liebig Transplant Center, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    HPB (Oxford) 13:356-60. 2011
  5. doi request reprint Successful liver transplantation for hilar cholangiocarcinoma
    Julie K Heimbach
    William J von Liebig Transplant Center, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    Curr Opin Gastroenterol 24:384-8. 2008
  6. doi request reprint Liver transplantation for hepatocellular carcinoma
    Julie K Heimbach
    William J von Liebig Transplant Center, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    Cancer J 14:95-9. 2008
  7. ncbi request reprint Liver transplantation for perihilar cholangiocarcinoma after aggressive neoadjuvant therapy: a new paradigm for liver and biliary malignancies?
    Julie K Heimbach
    William J von Liebig Transplant Center, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA
    Surgery 140:331-4. 2006
  8. doi request reprint Using implantation biopsies as a surrogate to evaluate selection criteria for living kidney donors
    Ashutosh Chauhan
    1 William J Von Liebig Transplant Center, Mayo Clinic College of Medicine, Rochester, MN 2 Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, MN 3 Address correspondence to Mark D Stegall, M D, Transplant Center, Rochester Methodist Hospital, 10th Floor, Charlton Building, 201 West Center Street, Rochester, MN 55902
    Transplantation 96:975-80. 2013
  9. ncbi request reprint Vascular complications after orthotopic liver transplantation after neoadjuvant therapy for hilar cholangiocarcinoma
    Hendrik T J Mantel
    William J von Liebig Transplant Center, Department of Radiology, Mayo Clinic Rochester and Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Liver Transpl 13:1372-81. 2007
  10. doi request reprint Impact of sirolimus and tacrolimus on mortality and graft loss in liver transplant recipients with or without hepatitis C virus: an analysis of the Scientific Registry of Transplant Recipients Database
    Kymberly D Watt
    Division of Gastroenterology and Hepatology, Mayo Clinic and Foundation Rochester, MN 55905, USA
    Liver Transpl 18:1029-36. 2012

Detail Information

Publications43

  1. ncbi request reprint Living donor liver transplantation using a right lobe graft in an adult with situs inversus
    Julie K Heimbach
    Division of Transplantation Surgery, Mayo Clinic, 200 First Street, Rochester, MN 55905, USA
    Liver Transpl 11:111-3. 2005
    ..This is the first report of a successful living donor right liver graft in an adult with end-stage liver disease secondary to primary sclerosing cholangitis and situs inversus totalis...
  2. doi request reprint Infrastructure, logistics and regulation of transplantation: UNOS
    Julie K Heimbach
    Division of Transplantation Surgery, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA Electronic address
    Anesthesiol Clin 31:659-66. 2013
    ..The intent of this review is to highlight the logistics required for transplantation as well as reviewing the current oversight of transplantation. ..
  3. ncbi request reprint Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma
    Julie K Heimbach
    William J von Liebig Transplant Center, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Transplantation 82:1703-7. 2006
    ..We reviewed our experience with the aim to identify clinicopathological predictors of disease recurrence...
  4. pmc Trans-peritoneal fine needle aspiration biopsy of hilar cholangiocarcinoma is associated with disease dissemination
    Julie K Heimbach
    William J von Liebig Transplant Center, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    HPB (Oxford) 13:356-60. 2011
    ..The aim of the present study was to determine whether patients who have undergone transperitoneal FNA of the primary tumour have a higher incidence of metastases...
  5. doi request reprint Successful liver transplantation for hilar cholangiocarcinoma
    Julie K Heimbach
    William J von Liebig Transplant Center, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    Curr Opin Gastroenterol 24:384-8. 2008
    ..The purpose of this review is to present recent data demonstrating the success of neoadjuvant therapy followed by liver transplantation for hilar cholangiocarcinoma...
  6. doi request reprint Liver transplantation for hepatocellular carcinoma
    Julie K Heimbach
    William J von Liebig Transplant Center, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    Cancer J 14:95-9. 2008
    ..In addition, the role of certain immunosuppressive agents such as sirolimus in the reducing HCC recurrence posttransplant remains unclear...
  7. ncbi request reprint Liver transplantation for perihilar cholangiocarcinoma after aggressive neoadjuvant therapy: a new paradigm for liver and biliary malignancies?
    Julie K Heimbach
    William J von Liebig Transplant Center, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA
    Surgery 140:331-4. 2006
  8. doi request reprint Using implantation biopsies as a surrogate to evaluate selection criteria for living kidney donors
    Ashutosh Chauhan
    1 William J Von Liebig Transplant Center, Mayo Clinic College of Medicine, Rochester, MN 2 Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, MN 3 Address correspondence to Mark D Stegall, M D, Transplant Center, Rochester Methodist Hospital, 10th Floor, Charlton Building, 201 West Center Street, Rochester, MN 55902
    Transplantation 96:975-80. 2013
    ..The goal of this study was to use implantation biopsies as a surrogate outcome marker to evaluate our living kidney donor selection criteria...
  9. ncbi request reprint Vascular complications after orthotopic liver transplantation after neoadjuvant therapy for hilar cholangiocarcinoma
    Hendrik T J Mantel
    William J von Liebig Transplant Center, Department of Radiology, Mayo Clinic Rochester and Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Liver Transpl 13:1372-81. 2007
    ..Liver transplantation with neoadjuvant therapy is associated with far higher rates of late arterial and portal venous complications, but these complications do not adversely affect patient and graft survival...
  10. doi request reprint Impact of sirolimus and tacrolimus on mortality and graft loss in liver transplant recipients with or without hepatitis C virus: an analysis of the Scientific Registry of Transplant Recipients Database
    Kymberly D Watt
    Division of Gastroenterology and Hepatology, Mayo Clinic and Foundation Rochester, MN 55905, USA
    Liver Transpl 18:1029-36. 2012
    ..This study confirms the association of tacrolimus with superior outcomes. Sirolimus should be used sparingly in recipients with HCV infections...
  11. doi request reprint Living donor kidney transplantation using laparoscopically procured multiple renal artery kidneys and right kidneys
    Marcio F Chedid
    Division of Transplantation Surgery, Department of Surgery and William von Liebig Transplant Center, Mayo Clinic, Rochester, MN 55905, USA
    J Am Coll Surg 217:144-52; discussion 152. 2013
    ..We aimed to evaluate the short- and long-term outcomes of recipients of LDKT using laparoscopically procured MRA and right kidneys...
  12. pmc Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma
    David J Rea
    Division of Gstroenterologic and General Surgery, Mayo Clinic College of Medicine, Rochester, MN, USA
    Ann Surg 242:451-8; discussion 458-61. 2005
    ..Compare survival after neoadjuvant therapy and liver transplantation with survival after resection for patients with hilar CCA...
  13. doi request reprint The course of posttransplant hepatitis C infection: comparative impact of donor and recipient source of the favorable IL28B genotype and other variables
    Andres Duarte-Rojo
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA
    Transplantation 94:197-203. 2012
    ..Its role on disease biology and progression is less clear. We characterized the effects of IL28B genotype on HCV recurrence, allograft histology, rate of SVR, and survival after liver transplantation (LT) in HCV...
  14. ncbi request reprint Transplantation for hilar cholangiocarcinoma
    Julie K Heimbach
    William J von Liebig Transplant Center, Mayo Clinic College of Medicine, Rochester, MN, USA
    Liver Transpl 10:S65-8. 2004
    ..4. Survival following liver transplantation for unresectable, perihilar CCAs, mass lesion if present <3 cm, is greater than 80% at 5 years. 5. Patients with intrahepatic CCAs are not eligible for liver transplantation...
  15. ncbi request reprint Obesity in living kidney donors: clinical characteristics and outcomes in the era of laparoscopic donor nephrectomy
    Julie K Heimbach
    Mayo Clinic College of Medicine, Department of Transplant Surgery, Rochester, Minnesota, USA
    Am J Transplant 5:1057-64. 2005
    ..While early results are encouraging, we advocate careful study of obese donors and do not support their widespread use until longer follow-up is available...
  16. doi request reprint Neoadjuvant therapy and liver transplantation for hilar cholangiocarcinoma: is pretreatment pathological confirmation of diagnosis necessary?
    Charles B Rosen
    Division of Transplantation Surgery, Mayo Clinic Rochester and Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    J Am Coll Surg 215:31-8; discussion 38-40. 2012
    ..Pathologic confirmation of CCA is notoriously difficult, and many patients have been treated based on clinical criteria without pathological confirmation...
  17. ncbi request reprint Liver transplantation for unresectable perihilar cholangiocarcinoma
    Julie K Heimbach
    William J von Liebig Transplant Center, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    Semin Liver Dis 24:201-7. 2004
    ..Neoadjuvant chemoradiotherapy with liver transplantation achieves excellent results for patients with localized, regional lymph node negative, hilar cholangiocarcinoma...
  18. doi request reprint Predictors of cardiovascular events after liver transplantation: a role for pretransplant serum troponin levels
    Elizabeth Coss
    Mayo Clinic Transplant Center, Mayo Clinic and Foundation, Rochester, MN 55905, USA
    Liver Transpl 17:23-31. 2011
    ..In conclusion, pretransplant elevated troponin levels, diabetes, and a history of cardiovascular disease, alone or in combination, are strongly associated with the occurrence of posttransplant cardiovascular events...
  19. pmc Nutritional status of patients with alcoholic cirrhosis undergoing liver transplantation: time trends and impact on survival
    Ashwani K Singal
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA
    Transpl Int 26:788-94. 2013
    ..Our findings support feasibility of liver transplantation for alcoholic cirrhotics with obesity and malnutrition...
  20. doi request reprint Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States
    Michael R Charlton
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Gastroenterology 141:1249-53. 2011
    ..The relative frequency of nonalcoholic steatohepatitis (NASH) as an indication for liver transplantation and comparative outcomes following transplantation are poorly understood...
  21. doi request reprint Excellent quality of life after liver transplantation for patients with perihilar cholangiocarcinoma who have undergone neoadjuvant chemoradiation
    Sarwa Darwish Murad
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA
    Liver Transpl 19:521-8. 2013
    ..These results are important in light of the continued debate about the feasibility of this aggressive treatment in patients with perihilar CCA...
  22. ncbi request reprint Patient and graft outcomes from older living kidney donors are similar to those from younger donors despite lower GFR
    Lourdes S Peña de la Vega
    Division of Nephrology and Hypertension, Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
    Kidney Int 66:1654-61. 2004
    ..Donor age adversely affects deceased-donor kidney transplant outcomes, but its influence on living-donor transplantation is less well characterized...
  23. doi request reprint Interleukin-28B and fibrosing cholestatic hepatitis in posttransplant hepatitis C: a case-control study and literature review
    Andres Duarte-Rojo
    Divisions of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN University of Arkansas for Medical Sciences, Little Rock, AR
    Liver Transpl 19:1311-7. 2013
    ..Collaborative studies with larger numbers of study subjects are needed in order to define these issues...
  24. pmc Predictors of pretransplant dropout and posttransplant recurrence in patients with perihilar cholangiocarcinoma
    Sarwa Darwish Murad
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA
    Hepatology 56:972-81. 2012
    ..8; P = 0.01), portal vein encasement (HR 3.3; P = 0.007), and residual tumor on explant (HR 9.8; P < 0.001). Primary sclerosing cholangitis (PSC), age, history of cholecystectomy, and waiting time were not independent predictors...
  25. doi request reprint Liver transplantation for cholangiocarcinoma
    Charles B Rosen
    Division of Transplantation Surgery, Mayo Clinic, Rochester, MN 55905, USA
    Transpl Int 23:692-7. 2010
    ....
  26. doi request reprint Transplantation for cholangiocarcinoma: when and for whom?
    David J Rea
    Division of Transplantation Surgery, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
    Surg Oncol Clin N Am 18:325-37, ix. 2009
    ..This approach has achieved results superior to standard surgical therapy, with 72% 5-year survival for patients with unresectable disease...
  27. pmc Long-term probability of and mortality from de novo malignancy after liver transplantation
    Kymberly D S Watt
    Division of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
    Gastroenterology 137:2010-7. 2009
    ..We analyzed a multicenter, prospectively obtained database to assess the probabilities of and risk factors for de novo malignancies in patients after liver transplantation...
  28. ncbi request reprint Early subclinical coronary artery calcification in young adults who were pediatric kidney transplant recipients
    Michael B Ishitani
    William J von Liebig Transplant Center, Mayo Medical School, Foundation and Clinic, Rochester, MN, USA
    Am J Transplant 5:1689-93. 2005
    ..These data suggest young adults who received pediatric kidney transplants are at increased risk for developing early CAC and need close monitoring to detect early CAD so as to prevent premature cardiac morbidity and mortality...
  29. doi request reprint Liver transplantation for perihilar cholangiocarcinoma
    Gregory J Gores
    William J von Liebig Transplant Center, Mayo College of Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Dig Dis 31:126-9. 2013
    ..In summary, neoadjuvant chemoradiation plus liver transplantation achieves excellent survival for patients with early-stage perihilar cholangiocarcinoma. ..
  30. doi request reprint Endoscopic ultrasound staging of cholangiocarcinoma
    Michael J Levy
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Curr Opin Gastroenterol 28:244-52. 2012
    ..In this review we examine the utility of endoscopic ultrasound (EUS), which is increasingly used in this setting to overcome the limitations of other imaging and biopsy techniques...
  31. doi request reprint Pretransplant serum troponin levels are highly predictive of patient and graft survival following liver transplantation
    Kymberly D S Watt
    Mayo Clinic Transplant Center, Rochester, MN 55905, USA
    Liver Transpl 16:990-8. 2010
    ..In summary, elevated pretransplant serum TN levels are strongly predictive of mortality and graft loss after liver transplantation and may be helpful in risk stratification of potential liver transplant recipients...
  32. doi request reprint Pulmonary contraindications, indications and MELD exceptions for liver transplantation: a contemporary view and look forward
    Michael J Krowka
    Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN 55905, United States
    J Hepatol 59:367-74. 2013
    ..Herein, we discuss current pulmonary-related contraindications, indications and MELD exception policies for liver transplantation, suggesting future considerations. ..
  33. pmc Frequency, clinical presentation, and outcomes of drug-induced liver injury after liver transplantation
    Stepan Sembera
    William J von Leibig Transplant Center, Mayo Clinic, Rochester, MN 55905, USA
    Liver Transpl 18:803-10. 2012
    ..In conclusion, DILI is a rare yet underrecognized event among LT recipients. The majority of cases are not clinically severe, and they resolve after drug cessation without hepatic retransplantation or death...
  34. doi request reprint Hepatopulmonary syndrome: favorable outcomes in the MELD exception era
    Vivek N Iyer
    Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Hepatology 57:2427-35. 2013
    ..Survival after LT was not associated with PaO2 levels at the time of HPS diagnosis. (HEPATOLOGY 2012)...
  35. pmc Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers
    Sarwa Darwish Murad
    William J von Liebig Transplant Center, Mayo Clinic, Rochester, Minnesota 55905, USA
    Gastroenterology 143:88-98.e3; quiz e14. 2012
    ..We analyzed data from multiple centers to determine the effectiveness of this treatment and the appropriateness of the MELD exception...
  36. ncbi request reprint Effect of the pretransplant serum sodium concentration on outcomes following liver transplantation
    Michael D Leise
    William J von Leibig Transplant Center, Mayo Clinic, Rochester, MN, Mayo Clinic, Rochester, MN
    Liver Transpl 20:687-97. 2014
    ..001). In conclusion, hyponatremia per se does not affect post-LT survival. Pre-LT hypernatremia is a highly significant risk factor for post-LT mortality...
  37. doi request reprint Changes in transfusion practice over time in adult patients undergoing liver transplantation
    James Y Findlay
    Department of Anesthesiology and Critical Care Medicine, Mayo Clinic, Rochester, MN 55905, USA
    J Cardiothorac Vasc Anesth 27:41-5. 2013
    ..The aim of this study was to investigate changes in transfusion practice over time in liver transplantation surgery and to evaluate potential causes for changes in practice and report associated perioperative morbidity and mortality...
  38. pmc Interleukin-28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infection
    Michael R Charlton
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA
    Hepatology 53:317-24. 2011
    ..0095). IL28B genotype was not significantly associated with survival (overall/liver-related)...
  39. pmc Free fatty acid storage in human visceral and subcutaneous adipose tissue: role of adipocyte proteins
    Asem H Ali
    Endocrine Research Unit, Mayo Clinic, Rochester, Minnesota, USA
    Diabetes 60:2300-7. 2011
    ..Because direct adipose tissue free fatty acid (FFA) storage may contribute to body fat distribution, we measured FFA (palmitate) storage rates and fatty acid (FA) storage enzymes/proteins in omental and abdominal subcutaneous fat...
  40. pmc APACHE III outcome prediction in patients admitted to the intensive care unit after liver transplantation: a retrospective cohort study
    Mark T Keegan
    Division of Critical Care, Department of Anesthesiology, Mayo Clinic, Rochester, MN, USA
    BMC Surg 9:11. 2009
    ..The area under the receiver operating characteristic curve (AUC) and the Hosmer-Lemeshow C statistic were used to assess, respectively, discrimination and calibration of APACHE III...
  41. ncbi request reprint Antibody-mediated rejection in liver transplantation: current controversies and future directions
    Timucin Taner
    William J von Liebig Transplantation Center, Mayo Clinic, Rochester, MN
    Liver Transpl 20:514-27. 2014
    ..Here we review the clinical literature, highlight controversial results, and propose a path forward for the definition and better understanding of antibody-mediated injury to the liver...
  42. ncbi request reprint Hand-assisted laparoscopic donor nephrectomy for pediatric kidney allograft recipients
    Dean Y Kim
    Department of Surgery, Division of Transplantation Surgery, William J von Liebig Transplant Center, Mayo Medical School, Foundation and Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Pediatr Transplant 8:460-3. 2004
    ..In conclusion, hand-assisted LDN is a safe method of procuring kidneys from potential donors with no significant negative outcomes to the pediatric recipients...
  43. ncbi request reprint Predicting failure of outpatient laparoscopic cholecystectomy
    Thomas N Robinson
    Department of Surgery, Denver Health Medical Center University of Colorado Health Sciences Center, USA
    Am J Surg 184:515-8; discussion 518-9. 2002
    ..We hypothesized that patients in whom same day discharge (SDD) is unlikely may be identified preoperatively...